Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraemar Shipping Regulatory News (BMS)

Share Price Information for Braemar Shipping (BMS)

Share Price is delayed by 15 minutes
Get Live Data
235.00    0.00 (0.00%)
Bid:
235.00
Ask:
238.00
Spread: 3.00 (1.277%)
Market Cap: £75.17m
BMS Live PriceLast checked at - London Stock Exchange

Intraday Braemar Shipping Share Chart

FY25 Trading Update

24 Mar 2025 07:00

RNS Number : 7360B
Braemar PLC
24 March 2025
 

 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU NO. 596/2014) WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

24 March 2025

BRAEMAR PLC

("Braemar", "the Company" and together with its subsidiaries the "Group")

 

FY25 TRADING UPDATE

Diversified business model delivers robust full year performance

 

Braemar Plc (LSE: BMS), a leading provider of expert investment, chartering and risk management advice to the shipping and energy markets, announces a trading update for the year ended 28 February 2025 ("FY25" or "the year").

Trading Update

Braemar is pleased to report that the Group's balanced and diversified business model performed well, during the year, to deliver a robust overall trading performance for FY25. Global charter rates, notably in the Tanker and Dry Cargo markets, came under pressure in the second half of the financial year, due to increased geopolitical volatility; however, the impact of this was partially offset by a strong performance in other parts of the Group such as Sale and Purchase. The board now expects revenue for FY25 to be in the region of £141.0m3 (FY24: £152.8m), with underlying operating profit (before acquisition-related expenditure) of c.£16.5m3 (FY24: £18.1m), subject to audit.

Operating cash flow remains strong, however, the timing of certain working capital items yielded a net debt position of £2.5m at 28 February 2025 (FY24: net cash £1.0m). The Group swiftly returned to a positive net cash position at the start of the new financial year.

Outlook

The Group's forward order book at the end of February 2025 was strong, having increased from H1 ($80.9m) to $82.2m (FY24: $82.6m) and fixture levels achieved in FY25 are expected to be maintained in the year ahead.

Whilst mindful of the short-term volatility in the Group's markets, the strong fundamental drivers of the global shipping markets and the scale and diversified breadth of the Group's operations underpin the board's confidence in the longer-term prospects for the business. The board remains focused on leveraging the integrated capabilities in the Group's core market segments and driving further growth, through both organic investment and strategic acquisitions.

Commenting, James Gundy, Group CEO of Braemar said:

"The Group has made significant strides to strengthen the business in recent years, and it is encouraging to see the benefits of our actions come through in FY25. We have diversified our revenue streams and improved our operational platform, creating a more balanced and insulated business, and in so doing reduced the impact of cyclical rate pressures on individual market segments.

Braemar is in a strong position, and we remain focused on driving further progress against our long-term, strategic plans to scale the business for the benefit of all stakeholders".

Notice of Results

The Group will announce its FY25 results for the year ended 28 February 2025 by the end of May 2025.

1. Underlying results measures above are before specific items

2. The total forward order book covers revenue that will be earned in future periods up until 2039

3. Company compiled consensus prior to the release of this announcement: revenue £152.0 million (£150.8 million - £153.7 million); underlying operating profit (before acquisition-related expenditure) £17.5 million (£17.1 million - £17.9 million)

 

Enquiries:

Braemar Plc

Tel: +44 (0)20 3142 4100

James Gundy, Group Chief Executive Officer

Grant Foley, Group Chief Financial Officer

Rebecca-Joy Wekwete, Company Secretary

Houston

Tel: +44 (0)20 4529 0549

Kate Hoare / Charlie Barker / Ben Robinson

Canaccord Genuity

Tel: +44 (0) 20 7523 8000

Adam James / Harry Rees

 

About Braemar Plc

Braemar provides expert advice in shipping investment, chartering, and risk management to enable its clients to secure sustainable returns and mitigate risk in the volatile world of shipping. Our experienced brokers work in tandem with specialist professionals to form teams tailored to our customers' needs, and provide an integrated service supported by a collaborative culture.

Braemar joined the Official List of the London Stock Exchange in November 1997 and trades under the symbol BMS.

For more information, including our investor presentation, visit www.braemar.com and follow Braemar on LinkedIn.

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTJBMATMTATBPA
Date   Source Headline
3rd Jun 20263:30 pmRNSNotice of AGM
2nd Jun 20265:03 pmRNSTotal Voting Rights
27th May 20267:00 amRNSBoard Changes
21st May 20267:00 amRNSFinal Results
13th May 20267:00 amRNSNotice of Results
1st May 202610:13 amRNSTotal Voting Rights
20th Apr 20264:32 pmRNSDirector/PDMR Shareholding
10th Apr 20263:26 pmRNSHolding(s) in Company
1st Apr 202610:32 amRNSTotal Voting Rights
25th Mar 20267:00 amRNSFY26 Trading Update
2nd Mar 20264:33 pmRNSTotal Voting Rights
17th Feb 20267:00 amRNSCEO Succession
2nd Feb 20265:13 pmRNSTotal Voting Rights
5th Jan 20267:00 amRNSIssue of Shares
2nd Jan 20261:49 pmRNSTotal Voting Rights
15th Dec 20257:00 amRNSIssue of Shares
2nd Dec 202511:27 amRNSTotal Voting Rights
5th Nov 20257:00 amRNSInterim Results
31st Oct 20257:00 amRNSTotal Voting Rights
27th Oct 20257:00 amRNSNotice of HY26 Results
1st Oct 202512:26 pmRNSTotal Voting Rights
25th Sep 20257:00 amRNSHY26 Trading Update
2nd Sep 202511:28 amRNSTransaction in Own Shares
1st Sep 202512:20 pmRNSTotal Voting Rights
1st Sep 20257:00 amRNSTransaction in Own Shares
29th Aug 20257:00 amRNSTransaction in Own Shares
28th Aug 20257:00 amRNSTransaction in Own Shares
27th Aug 20257:00 amRNSTransaction in Own Shares
26th Aug 20257:00 amRNSTransaction in Own Shares
22nd Aug 20259:46 amRNSTransaction in Own Shares
21st Aug 20257:00 amRNSTransaction in Own Shares
20th Aug 20257:00 amRNSTransaction in Own Shares
19th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 20257:00 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSTransaction in Own Shares
24th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 20257:00 amRNSTransaction in Own Shares
22nd Jul 20257:00 amRNSTransaction in Own Shares
17th Jul 20257:00 amRNSTransaction in Own Shares
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 20257:00 amRNS-ROpening of First African Office in Cape Town
14th Jul 20257:00 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
10th Jul 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.